While the knowledge that HDAC inhibitors upregulate MHC-1 molecule expression in cancer is not new (99–103), this study extended the findings to gliomas and, more importantly, detailed the association between HDAC regulation of MHC1 expression and maintenance of the stem cell phenotype. This evidence concerns the gene HDAC9 and glioma.